← Eichor
Condition: Cryptosporidium Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cryptosporidium Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants
Phase N/A · 4 location(s) · Novartis Pharmaceuticals · NCT07716410
The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children
Phase 2 · 1 location(s) · Al-Azhar University · NCT07388615
Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
Phase 2 · 2 location(s) · Novartis Pharmaceuticals · NCT07249463
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.